Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/17839
Title: Effects of Clonidine on the Cardiovascular, Renal and Inflammatory Responses to Experimental Bacteremia.
Authors: Calzavacca, Paolo;Booth, Lindsea C;Lankadeva, Yugeesh R;Bailey, Simon R;Burrell, Louise M;Bailey, Michael;Bellomo, Rinaldo;May, Clive N
Affiliation: Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Victoria, Australia
School of Medicine, University of Melbourne, Parkville, Victoria, Australia
Department of Anaesthesia and Intensive Care, ASST Melegnano e della Martesana, PO Uboldo, Cernusco sul Naviglio, Italy
Faculty of Veterinary Science, University of Melbourne, Melbourne, Victoria, Australia
Department of Medicine, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australia
Australian and New Zealand Intensive Care Research Centre, School of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia
Issue Date: 27-Feb-2018
EDate: 2018-02-27
Citation: Shock (Augusta, Ga.) 2018; online first: 27 February
Abstract: Supra-clinical doses of clonidine appear beneficial in experimental sepsis, but there is limited understanding of the effects of clonidine at clinically relevant doses. In conscious sheep, with implanted renal and pulmonary artery flow probes, sepsis was induced by infusion of live Escherichia coli. At 24 hours, a high clinical dose of clonidine (HCDC) [1.0 μg/kg/h], a low clinical dose of clonidine (LCDC) [0.25 μg/kg/h] or vehicle, was infused for 8 hours. Animals developed hyperdynamic, hypotensive sepsis with acute kidney injury. The HCDC decreased heart rate (153 ± 6 to 119 ± 7 bpm) and cardiac output (5.6 ± 0.4 to 5.0 ± 0.4 L/min), with no reduction in mean arterial pressure (MAP). In contrast, LCDC increased cardiac output with peripheral vasodilatation. Both doses induced a large transient increase in urine output, an increase in plasma osmolality and, with the high dose, an increase in plasma arginine vasopressin. Sepsis increased plasma interleukin-6 (IL-6) and IL-10 and clonidine further increased IL-10 (1.6 ± 0.1 to 3.3 ± 0.7 ng/mL), but not IL-6. Clonidine reduced rectal temperature. During recovery from sepsis, MAP returned to baseline values more rapidly in the HCDC group (p < 0.001). In hyperdynamic, hypotensive sepsis, the effects of clonidine at clinically relevant doses are complex and dose dependent. HCDC attenuated sepsis-related increases in heart rate and cardiac output, with little effect on arterial pressure. It also induced a water diuresis, increased AVP, reduced body temperature and had an anti-inflammatory action. Low-dose clonidine had similar but less pronounced effects, except that it induced moderate vasodilatation and increased cardiac output.
URI: http://ahro.austin.org.au/austinjspui/handle/1/17839
DOI: 10.1097/SHK.0000000000001134
ORCID: 0000-0002-1650-8939
0000-0003-1863-7539
PubMed URL: 29489737
Type: Journal Article
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.